Načítá se...
Timing and Targeting of Treatment in Left Ventricular Hypertrophy
In most clinical cases, left ventricular hypertrophy (LVH) occurs over time from persistent cardiac stress. At the molecular level, this results in both transient and long-term changes to metabolic, sarcomeric, ion handling, and stress signaling pathways. Although this is initially an adaptive chang...
Uloženo v:
| Vydáno v: | Methodist Debakey Cardiovasc J |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Methodist Hospital Houston, Texas
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385802/ https://ncbi.nlm.nih.gov/pubmed/28413576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-13-1-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|